Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Daniele, Compagnone"'
Publikováno v:
British Journal of Clinical Pharmacology. 45:491-495
Aims To investigate the dose-response relationship and contribution of verapamil SR and trandolapril given in combination once a day for the treatment of essential hypertension. Methods A randomized, double-blind, placebo controlled, factorial, 12 ar
Publikováno v:
Current Therapeutic Research. 58:343-351
The 24-hour ambulatory blood pressure response to daily treatment with verapamil sustained release (SR) 180 mg once daily, trandolapril 2 mg once daily, or verapamil SR 180 mg/trandolapril 2 mg once daily was investigated in a randomized, double-mask
Publikováno v:
Current Therapeutic Research. 58:331-342
We compared the efficacy of fixed combination therapy with verapamil sustained release (SR)/trandolapril with that of each agent alone in a randomized, double-masked, parallel-group, multicenter study involving 310 patients (180 men and 130 women; me
Autor:
Manfred Denker, Daniele Compagnone
Publikováno v:
Journal of Nonparametric Statistics. 7:123-154
We prove asymptotic normality of simple linear rank statistics when the observations have U-statistic structure. This type of statistic can be used for testing the location parameter and/or the scale parameter in a scale-location model. It is shown t
Autor:
Daniel E, Furst, Michael H, Schiff, Roy M, Fleischmann, Vibeke, Strand, Charles A, Birbara, Daniele, Compagnone, Steven A, Fischkoff, Elliot K, Chartash
Publikováno v:
The Journal of rheumatology. 30(12)
This study, known as STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis), evaluated the safety and efficacy of adalimumab (Humira), a fully human monoclonal tumor necrosis factor-alpha (TNF-a) antibody, when given with standard antirheumatic th
Publikováno v:
Current Controlled Trials in Cardiovascular Medicine, Vol 4, Iss 1, p 2 (2003)
Current Controlled Trials in Cardiovascular Medicine
Current Controlled Trials in Cardiovascular Medicine
Background A large body of data derived from animal, epidemiological and clinical studies indicate that n-3 polyunsaturated fatty acids have a favourable effect on the prognosis of patients with cardiovascular disease in general, and on reducing sudd
Autor:
Daniele Compagnone
Publikováno v:
Biometrical Journal. 50:450-450
Publikováno v:
Controlled Clinical Trials. 12:697-698